K36 Therapeutics is a Biotech company based in Cambridge, Massachusetts. It has raised $100M in total funding. Latest round: Series B.
K36 Therapeutics is a Biotech company based in Cambridge, Massachusetts. K36 Therapeutics has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2023. The round record for K36 Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include F-Prime Capital, Atlas Venture, Eight Roads Ventures. 3 distinct backers are named across the disclosed rounds.
Every K36 Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Cambridge at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026